STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G

BLFS Schedule 13G filing by Invesco

Invesco reported beneficial ownership of 3.2M shares, representing 7% of BIOLIFE SOLUTIONS INC in this filing.

FiledNov 8, 2024
Ownership dateSep 30, 2024
Reported shares3.2M
Reported ownership7%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 3.2M
Shared voting power 3.2M
Sole dispositive power 3.2M
Shared dispositive power 3.2M
Price context

Price dates alongside the ownership filing

Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.

Close near filing date$26.13as of Nov 8, 2024
Latest tracked price$33.80as of Aug 5, 2026
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
Invesco
CIK
CIK0000914208
Accession
0000914208-24-000511
Form
Schedule 13G
Open SEC filing View BLFS ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →